Susquehanna International »

Crispr Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $93M 1.4M 68.16
2023-09-30 $36M 799k 45.39
2023-06-30 $47M 845k 56.14
2023-03-31 $34M 760k 45.23
2022-12-31 $29M 716k 40.65
2022-09-30 $56M 863k 65.35
2022-06-30 $56M 918k 60.76
2022-03-31 $61M 975k 62.77
2021-12-31 $102M 1.3M 75.81
2021-09-30 $139M 1.2M 111.93
2021-06-30 $227M 1.4M 161.89
2021-03-31 $187M 1.5M 121.83
2020-12-31 $148M 967k 153.11
2020-09-30 $51M 607k 83.64
2020-06-30 $62M 843k 73.49
2020-03-31 $25M 592k 42.34
2019-12-31 $48M 780k 60.91
2019-09-30 $21M 522k 40.99
2019-06-30 $29M 615k 47.10
2019-03-31 $26M 735k 35.72
2018-12-31 $19M 658k 28.57
2018-09-30 $47M 1.1M 44.35
2018-06-30 $58M 983k 58.76
2018-03-31 $33M 715k 45.71
2017-12-31 $3.4M 146k 23.50
2017-09-30 $1.4M 78k 17.88
2017-06-30 $320k 20k 16.00